Serotonin type 3–receptor antagonists for chemotherapy-induced nausea and vomiting: Therapeutically equivalent or meaningfully different?

類似資料

• The serotonin type 3 receptor antagonist BRL 43694 and nausea and vomiting induced by cisplatin.
  著者:: Carmichael, J., 等
  出版事項: (1988)
• Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting
  著者:: Navari RM, 等
  出版事項: (2018-10-01)
• Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting
  著者:: Navari, Rudolph M, 等
  出版事項: (2018)
• Casopitant: a novel NK(1)-receptor antagonist in the prevention of chemotherapy-induced nausea and vomiting
  著者:: Ruhlmann, Christina, 等
  出版事項: (2009)
• The impact of 5-hydroxytryptamine-receptor antagonists on chemotherapy treatment adherence, treatment delay, and nausea and vomiting
  著者:: Palli, Swetha Rao, 等
  出版事項: (2015)